General Information
Drug ID
DR00151
Drug Name
Pomalidomide
Synonyms
Actimid (TN); Pomalidomide (Immunomodulator)
Drug Type
Small molecular drug
Indication Systemic sclerosis [ICD11: 4A42.0] Approved [1]
Structure
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=134780"></iframe>
3D MOL 2D MOL
Formula
C13H11N3O4
Canonical SMILES
C1CC(=O)NC(=O)C1N2C(=O)C3=C(C2=O)C(=CC=C3)N
InChI
InChI=1S/C13H11N3O4/c14-7-3-1-2-6-10(7)13(20)16(12(6)19)8-4-5-9(17)15-11(8)18/h1-3,8H,4-5,14H2,(H,15,17,18)
InChIKey
UVSMNLNDYGZFPF-UHFFFAOYSA-N
CAS Number
CAS 19171-19-8
Pharmaceutical Properties Molecular Weight 273.248 Topological Polar Surface Area 110
Heavy Atom Count 20 Rotatable Bond Count 1
Hydrogen Bond Donor Count 2 Hydrogen Bond Acceptor Count 5
XLogP
0.2
PubChem CID
134780
PubChem SID
10243744 , 103100612 , 103221733 , 104253216 , 104382952 , 117621779 , 124757341 , 125164145 , 125697093 , 129427476 , 135089995 , 135727444 , 136348254 , 136367549 , 136946644 , 137009922 , 142523166 , 143499180 , 14848461 , 149539643 , 152235120 , 152258286 , 152343904 , 160647125 , 160837107 , 162011791 , 162012270 , 162037668 , 162189531 , 162856472 , 163398415 , 163778934 , 163907985 , 164194051 , 172889447 , 172889448 , 173130995 , 174007398 , 174528127 , 175424471 , 175427148 , 178103920 , 179116970 , 186007045 , 29312424 , 50086901 , 50447747 , 53787052 , 57345004 , 96025659
ChEBI ID
ChEBI:72690
TTD Drug ID
D0A3ZU
DT(s) Transporting This Drug P-GP Transporter Info P-glycoprotein 1 Substrate [2]
References
1 Pomalidomide was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2018 Jan 4;46(D1):D1074-D1082. (ID: DB08910)

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.